New York applications ongoing until September 12th

Learn more about investing in Capra Biosciences

Our team will get back to you soon to follow up on your inquiry.
Lead Rounds?
Capra Biosciences
Our planet is riddled with petroleum. Bacterial biofilms to rescue
Funding to Date*
Liz Onderko, Ph.D, CEO
In the future, even motor oil won't be made from motor oil
Capra's bioreactor costs only $1000 to make, uses 100X less water, and can sell bio-derived retinol at 90% margins.

In fermentation, biologists focus on free-floating bacteria and yeast for making products today – and if biofilms develop, it’s a big problem.

Capra reverses that equation. In nature, 99% of all bacteria exist in the biofilm state, and at Capra, biofilms are the solution. Biofilms mean more cells packed tightly together, working together as a team. Capra designed their unique bioreactor around this unique insight, resulting resulting in a process that requires less infrastructure, up to 100X water, and minimal downstream processing. These bring cost savings up to 90% on CAPEX and OPEX.

Capra is making high performance lubricants for the $150 billion motor oil market. But first they’re making a bio-Retinol for the cosmetics market.